Nova Cannabis Inc (NOVC.TO)
1.25
+0.02
(+1.63%)
CAD |
TSX |
May 17, 16:00
Nova Cannabis Enterprise Value: 72.45M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 72.45M |
May 16, 2024 | 71.31M |
May 15, 2024 | 71.31M |
May 14, 2024 | 72.45M |
May 13, 2024 | 69.59M |
May 10, 2024 | 74.75M |
May 09, 2024 | 73.60M |
May 08, 2024 | 74.75M |
May 07, 2024 | 81.05M |
May 06, 2024 | 76.96M |
May 03, 2024 | 82.12M |
May 02, 2024 | 78.11M |
May 01, 2024 | 77.53M |
April 30, 2024 | 80.97M |
April 29, 2024 | 79.25M |
April 26, 2024 | 78.68M |
April 25, 2024 | 77.53M |
April 24, 2024 | 81.54M |
April 23, 2024 | 82.12M |
April 22, 2024 | 82.12M |
April 19, 2024 | 92.42M |
April 18, 2024 | 93.57M |
April 17, 2024 | 92.42M |
April 16, 2024 | 101.01M |
April 15, 2024 | 101.01M |
Date | Value |
---|---|
April 12, 2024 | 88.99M |
April 11, 2024 | 97.01M |
April 10, 2024 | 96.43M |
April 09, 2024 | 102.73M |
April 08, 2024 | 103.88M |
April 05, 2024 | 104.45M |
April 04, 2024 | 103.88M |
April 03, 2024 | 109.03M |
April 02, 2024 | 101.59M |
April 01, 2024 | 101.01M |
March 31, 2024 | 102.16M |
March 28, 2024 | 102.55M |
March 27, 2024 | 102.55M |
March 26, 2024 | 104.27M |
March 25, 2024 | 101.98M |
March 22, 2024 | 103.59M |
March 21, 2024 | 104.73M |
March 20, 2024 | 104.73M |
March 19, 2024 | 103.01M |
March 18, 2024 | 101.30M |
March 15, 2024 | 102.44M |
March 14, 2024 | 102.44M |
March 13, 2024 | 103.59M |
March 12, 2024 | 104.16M |
March 11, 2024 | 105.30M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
25.70M
Minimum
Dec 05 2022
224.33M
Maximum
Oct 07 2021
87.26M
Average
62.67M
Median
Enterprise Value Benchmarks
Relevium Technologies Inc | -- |
Gaby Inc | -- |
High Tide Inc | 238.67M |
PeakBirch Commerce Inc | -- |
Neighbourly Pharmacy Inc (DELISTED) | 1.082B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.333M |
Revenue (Quarterly) | 64.26M |
Total Expenses (Quarterly) | 62.35M |
EPS Diluted (Quarterly) | -0.01 |
Gross Profit Margin (Quarterly) | 24.56% |
Profit Margin (Quarterly) | -0.52% |
Earnings Yield | 4.00% |
Operating Earnings Yield | 16.65% |
Normalized Earnings Yield | 9.619 |